PDK1 and cancer: Activated Wnt signaling has been implicated in the enhancement of glycolytic activity in cancer cells, e.g., in nasopharyngeal carcinoma via the upregulation of pyruvate dehydrogenase kinase 1 [22] or by increasing glucose uptake in hepatocellular carcinoma [23].